Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · IEX Real-Time Price · USD
19.78
-0.88 (-4.26%)
At close: Jul 2, 2024, 4:00 PM
20.38
+0.60 (3.03%)
After-hours: Jul 2, 2024, 6:55 PM EDT
Rocket Pharmaceuticals Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for RCKT stock have an average target of 53.56, with a low estimate of 39 and a high estimate of 65. The average target predicts an increase of 170.78% from the current stock price of 19.78.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for RCKT stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 5 | 5 | 5 |
| Buy | 4 | 4 | 4 | 4 | 3 | 3 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 9 | 10 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $62 | Strong Buy | Maintains | $62 | +213.45% | Jun 28, 2024 |
| Needham | Needham | Strong Buy Maintains $53 → $52 | Strong Buy | Maintains | $53 → $52 | +162.89% | Jun 28, 2024 |
| Needham | Needham | Strong Buy Reiterates $53 | Strong Buy | Reiterates | $53 | +167.95% | May 7, 2024 |
| Needham | Needham | Strong Buy Reiterates $53 | Strong Buy | Reiterates | $53 | +167.95% | Apr 10, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $39 | Hold | Initiates | $39 | +97.17% | Apr 2, 2024 |
Financial Forecast
Revenue This Year
26.81M
Revenue Next Year
157.71M
from 26.81M
Increased by 488.18%
EPS This Year
-2.68
from -2.92
EPS Next Year
-2.10
from -2.68
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 105.4M | 328.7M | 843.8M | 1.4B | 2.0B |
| Avg | 26.8M | 157.7M | 513.0M | 1.0B | 1.7B |
| Low | 784,000 | 22.6M | 185.7M | 793.8M | 1.3B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 1,125.7% | 435.0% | 172.9% | 99.3% |
| Avg | - | 488.2% | 225.3% | 99.4% | 64.6% |
| Low | - | -15.6% | 17.8% | 54.7% | 28.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.51 | -0.57 | 2.51 | 3.31 | 8.03 |
| Avg | -2.68 | -2.10 | 0.06 | 2.75 | 6.17 |
| Low | -3.24 | -2.96 | -1.22 | 1.87 | 4.00 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 5,088.2% | 192.0% |
| Avg | - | - | - | 4,214.7% | 124.3% |
| Low | - | - | - | 2,836.2% | 45.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.